Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prognostic Stage IIIA Breast Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03505736
What this trial is testing

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
Wake Forest University Health Sciences 25
Testing effectiveness (Phase 2)Study completedNCT00524277
What this trial is testing

Vaccine Therapy in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
San Antonio Military Medical Center 456
Not applicableStudy completedNCT00445445
What this trial is testing

Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 2,201
Testing effectiveness (Phase 2)Study completedNCT00008437
What this trial is testing

MRI-Guided Ultrasound Energy in Treating Patients With Stage I, Stage II, or Stage IIIA Breast Cancer

Who this might be right for
Breast Cancer
InSightec
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Active Not RecruitingNCT01463072
What this trial is testing

Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced Breast CarcinomaMetastatic Breast CarcinomaRecurrent Breast Carcinoma+5 more
City of Hope Medical Center 40
Not applicableStudy completedNCT00087347
What this trial is testing

Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer

Who this might be right for
Breast CancerProstate Cancer
Massachusetts General Hospital 14
Early research (Phase 1)Study completedNCT02060253
What this trial is testing

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+4 more
Memorial Sloan Kettering Cancer Center 9
Not applicableStudy completedNCT00897845
What this trial is testing

Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer

Who this might be right for
Breast Cancer
ECOG-ACRIN Cancer Research Group 2,541
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004092
What this trial is testing

Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 72
Testing effectiveness (Phase 2)Study completedNCT00020332
What this trial is testing

Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT00516698
What this trial is testing

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 140
Large-scale testing (Phase 3)Study completedNCT03324802
What this trial is testing

Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery

Who this might be right for
Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+4 more
Mayo Clinic 107
Not applicableStudy completedNCT03319342
What this trial is testing

Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors

Who this might be right for
Cancer SurvivorStage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7+6 more
Jonsson Comprehensive Cancer Center 133
Not applicableEnded earlyNCT05452681
What this trial is testing

Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors

Who this might be right for
Breast CancerAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+18 more
University of Alabama at Birmingham 27
Testing effectiveness (Phase 2)WithdrawnNCT05177796
What this trial is testing

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+10 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00093795
What this trial is testing

Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 4,894
Early research (Phase 1)Study completedNCT02152943
What this trial is testing

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor PositiveHER2/Neu Positive+10 more
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00482391
What this trial is testing

Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 95
Next Page